Truncated tetrahedral RNA nanostructures exhibit enhanced features for delivery of RNAi substrates.


Journal

Nanoscale
ISSN: 2040-3372
Titre abrégé: Nanoscale
Pays: England
ID NLM: 101525249

Informations de publication

Date de publication:
28 Jan 2020
Historique:
pubmed: 15 1 2020
medline: 15 12 2020
entrez: 15 1 2020
Statut: ppublish

Résumé

Using RNA as a material for nanoparticle construction provides control over particle size and shape at the nano-scale. RNA nano-architectures have shown promise as delivery vehicles for RNA interference (RNAi) substrates, allowing multiple functional entities to be combined on a single particle in a programmable fashion. Rather than employing a completely bottom-up approach to scaffold design, here multiple copies of an existing synthetic supramolecular RNA nano-architecture serve as building blocks along with additional motifs for the design of a novel truncated tetrahedral RNA scaffold, demonstrating that rationally designed RNA assemblies can themselves serve as modular pieces in the construction of larger rationally designed structures. The resulting tetrahedral scaffold displays enhanced characteristics for RNAi-substrate delivery in comparison to similar RNA-based scaffolds, as evidenced by its increased functional capacity, increased cellular uptake and ultimately an increased RNAi efficacy of its adorned Dicer substrate siRNAs. The unique truncated tetrahedral shape of the nanoparticle core appears to contribute to this particle's enhanced function, indicating the physical characteristics of RNA scaffolds merit significant consideration when designing platforms for delivery of functional RNAs via RNA nanoparticles.

Identifiants

pubmed: 31932830
doi: 10.1039/c9nr08197f
doi:

Substances chimiques

Cell Cycle Proteins 0
Proto-Oncogene Proteins 0
RNA, Small Interfering 0
Green Fluorescent Proteins 147336-22-9
RNA 63231-63-0
Protein Serine-Threonine Kinases EC 2.7.11.1
DICER1 protein, human EC 3.1.26.3
Ribonuclease III EC 3.1.26.3
DEAD-box RNA Helicases EC 3.6.4.13

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2555-2568

Auteurs

Paul Zakrevsky (P)

RNA Biology Laboratory, National Cancer Institute, Frederick, MD 21702, USA. shapirbr@mail.nih.gov.

Wojciech K Kasprzak (WK)

Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.

William F Heinz (WF)

Optical Microscopy and Analysis Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.

Weimin Wu (W)

Center for Molecular Microscopy, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA.

Htet Khant (H)

Center for Molecular Microscopy, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA.

Eckart Bindewald (E)

Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.

Nomongo Dorjsuren (N)

RNA Biology Laboratory, National Cancer Institute, Frederick, MD 21702, USA. shapirbr@mail.nih.gov.

Eric A Fields (EA)

RNA Biology Laboratory, National Cancer Institute, Frederick, MD 21702, USA. shapirbr@mail.nih.gov.

Natalia de Val (N)

Center for Molecular Microscopy, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA and Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc, Frederick, MD 21701, USA.

Luc Jaeger (L)

Department of Chemistry and Biochemistry, Biomolecular Science and Engineering Program, University of California, Santa Barbara, CA 93106-9510, USA. jaeger@chem.ucsb.edu.

Bruce A Shapiro (BA)

RNA Biology Laboratory, National Cancer Institute, Frederick, MD 21702, USA. shapirbr@mail.nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH